Literature DB >> 15818297

Pediatric aspergillosis: disease and treatment differences in children.

William J Steinbach1.   

Abstract

Invasive aspergillosis is an increasing problem, yet there are few specific data on pediatric aspergillosis. The underlying patient diseases and treatments differ in children and adults, and there is a heterogeneity of invasive aspergillosis that extends to children. Although new diagnostic tools hold great promise for adult patients, it appears that they have limited usefulness in children without the appropriate testing. Antifungal management of pediatric aspergillosis also requires unique dosing schemes that are not used in adult patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818297     DOI: 10.1097/01.inf.0000157218.37603.84

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  CNS-manifestation of aspergillosis in an extremely low-birth-weight infant.

Authors:  Hans Fuchs; Heike von Baum; Martina Meth; Nele Wellinghausen; Wolfgang Lindner; Helmut Hummler
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

2.  Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.

Authors:  H-C Hsiue; T-H Wu; T-C Chang; Y-C Hsiue; Y-T Huang; P-I Lee; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

Review 3.  Invasive fungal infections in neonates: a review.

Authors:  Kristin E D Weimer; P Brian Smith; Mihai Puia-Dumitrescu; Samia Aleem
Journal:  Pediatr Res       Date:  2021-12-09       Impact factor: 3.756

4.  Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.

Authors:  Hossein Zarrinfar; Hossein Mirhendi; Koichi Makimura; Kazuo Satoh; Hossein Khodadadi; Omolbanin Paknejad
Journal:  Mycopathologia       Date:  2013-09-18       Impact factor: 2.574

5.  Pediatric antifungal utilization: new drugs, new trends.

Authors:  Priya A Prasad; Susan E Coffin; Kateri H Leckerman; Thomas J Walsh; Theoklis E Zaoutis
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

Review 6.  Antifungal agents in neonates: issues and recommendations.

Authors:  Benito Almirante; Dolors Rodríguez
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

8.  Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease.

Authors:  Hyeong Jin Lee; Bongjin Lee; June Dong Park; Hyung Joo Jeong; Yu Hyeon Choi; Hee Young Ju; Che Ry Hong; Ji Won Lee; Hyery Kim; Dong In Suh; Kyung Duk Park; Hyoung Jin Kang; Hee Young Shin; Hyo Seop Ahn
Journal:  Drug Des Devel Ther       Date:  2015-12-17       Impact factor: 4.162

9.  Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study.

Authors:  Natalia Mendoza-Palomar; Beatriz Garcia-Palop; Susana Melendo; Maria Teresa Martín; Berta Renedo-Miró; Pere Soler-Palacin; Aurora Fernández-Polo
Journal:  BMC Infect Dis       Date:  2021-01-22       Impact factor: 3.090

10.  Invasive aspergillosis in a patient with end stage renal disease.

Authors:  Neslihan Cicek; Nurdan Yildiz; Eda Kepenekli Kadayifci; Ibrahim Gokce; Harika Alpay
Journal:  Med Mycol Case Rep       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.